IGF2 and liver disorder: Biochemical overviews underscore that IGFBP-6 is uniquely IGF-II-preferring among IGFBPs, so any post-translational modification that weakens IGF-II affinity would be expected to have disproportionate consequences for IGF signaling in liver disease [65].